Table 1.
Clinical characteristics of the 165 patients in this study
| n = 165 | |
|---|---|
| Age, years | 72 (45–83) |
| Gender | |
| Men | 89 (54) |
| Women | 76 (46) |
| BMI, kg/m2 | 20.8 (16.4–30.2) |
| Surgical procedure | |
| PD | 17 (10) |
| PpPD | 86 (52) |
| SSpPD | 62 (38) |
| PVR | |
| None | 61 (37) |
| End-to-end anastomosis | 79 (48) |
| Graft construction | 25 (15) |
| Operative time, min | 299 (198–664) |
| Blood loss, mL | 410 (100–4,900) |
| Blood transfusion | |
| Absent | 147 (89) |
| Present | 18 (11) |
| Adjuvant chemotherapy | |
| Neoadjuvant therapy | 8 (5) |
| Postoperative adjuvant therapy | 66 (40) |
| Histological type | |
| Well differentiated | 12 (7) |
| Moderately differentiated | 129 (78) |
| Poorly differentiated | 16(10) |
| Other | 8 (5) |
Expressed as n (%) or median (range).
PD, pancreatoduodenectomy; PpPD, pylorus-preserving PD; SSpPD, sub-stomach preserving PD; PVR, portal vein resection; SMV, superior mesenteric vein; BMI, body mass index.